175
Views
23
CrossRef citations to date
0
Altmetric
Original

Fetal plasma cortisol and dehydroepiandrosterone sulfate concentrations in pregnancy and term parturition

, , , , & , MD, PhD
Pages 529-536 | Received 23 Mar 2005, Accepted 07 Jun 2005, Published online: 07 Jul 2009

References

  • Challis J RG, Matthews S G, Gibb W, Lye S J. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000; 21: 514–550
  • Challis J, Sloboda D, Matthews S, Holloway A, Alfaidy N, Howe D, Fraser M, Newnham J. Fetal hypothalamic–pituitary–adrenal (HPA) development and activation as a determinant of the timing of birth, and of postnatal disease. Endocr Res 2000; 26: 489–504
  • Challis J R, Smith S K. Fetal endocrine signals and preterm labor. Biol Neonate 2001; 79: 163–167
  • Jenkin G, Young I R. Mechanisms responsible for parturition; the use of experimental models. Anim Reprod Sci 2004; 82–83: 567–581
  • Nathanielsz P W. Timing of birth. American scientist 1996; 84: 562
  • Liggins G C, Fairclough R J, Grieves S A, Kendall J Z, Knox B S. The mechanism of initiation of parturition in the ewe. Recent Prog Horm Res 1973; 29: 111–159
  • Walsh S W, Stanczyk F Z, Novy M J. Daily hormonal changes in the maternal, fetal, and amniotic fluid compartments before parturition in a primate species. J Clin Endocrinol Metab 1984; 58: 629–639
  • Hercz P, Siklos P, Ungar L. Serum dehydroepiandrosterone and cortisol concentration in the maternal–fetoplacental hormonal system in elective caesarean section and spontaneous vaginal delivery in the 28th to 36th and 40th weeks of pregnancy. Gynecol Obstet Invest 1990; 29: 112–114
  • Murphy V E, Clifton V L. Alterations in human placental 11beta-hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour. Placenta 2003; 24: 739–744
  • Lao T T, Panesar N S. The effect of labour on prolactin and cortisol concentrations in the mother and the fetus. Eur J Obstet Gynecol Reprod Biol 1989; 30: 233–238
  • Mears K, McAuliffe F, Grimes H, Morrison J J. Fetal cortisol in relation to labour, intrapartum events and mode of delivery. J Obstet Gynaecol 2004; 24: 129–132
  • Mastorakos G, Ilias I. Maternal and fetal hypothalamic–pituitary–adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci 2003; 997: 136–149
  • Parker C R, Jr, Favor J K, Carden L G, Brown C H. Effects of intrapartum stress on fetal adrenal function. Am J Obstet Gynecol 1993; 169: 1407–1411
  • Ramin S M, Porter J C, Gilstrap L C, 3rd, Rosenfeld C R. Stress hormones and acid–base status of human fetuses at delivery. J Clin Endocrinol Metab 1991; 73: 182–186
  • Giannakoulopoulos X, Sepulveda W, Kourtis P, Glover V, Fisk N M. Fetal plasma cortisol and beta-endorphin response to intrauterine needling. Lancet 1994; 344: 77–81
  • Gitau R, Menson E, Pickles V, Fisk N M, Glover V. Umbilical cortisol levels as an indicator of the fetal stress response to assisted vaginal delivery. Eur J Obstet Gynecol Reprod Biol 2001; 98: 14–17
  • Nahoul K, Daffos F, Forestier F, Scholler R. Cortisol, cortisone and dehydroepiandrosterone sulfate levels in umbilical cord and maternal plasma between 21 and 30 weeks of pregnancy. J Steroid Biochem 1985; 23: 445–450
  • Economides D L, Nicolaides K H, Linton E A, Perry L A, Chard T. Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Ther 1988; 3: 158–164
  • Donaldson A, Nicolini U, Symes E K, Rodeck C H, Tannirandorn Y. Changes in concentrations of cortisol, dehydroepiandrosterone sulphate and progesterone in fetal and maternal serum during pregnancy. Clin Endocrinol (Oxf) 1991; 35: 447–451
  • Yoon B H, Romero R, Jun J K, Maymon E, Gomez R, Mazor M, Park J S. An increase in fetal plasma cortisol but not dehydroepiandrosterone sulfate is followed by the onset of preterm labor in patients with preterm premature rupture of the membranes. Am J Obstet Gynecol 1998; 179: 1107–1114
  • Cortelazzi D, Cappiello V, Morpurgo P S, Ronzoni S, Nobile De Santis M S, Cetin I, Beck-Peccoz P, Spada A. Circulating levels of ghrelin in human fetuses. Eur J Endocrinol 2003; 149: 111–116
  • Karalis K, Goodwin G, Majzoub J A. Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor. Nat Med 1996; 2: 556–560
  • Majzoub J A, Karalis K P. Placental corticotropin-releasing hormone: Function and regulation. Am J Obstet Gynecol 1999; 180: S242–S246
  • Robinson B G, Emanuel R L, Frim D M, Majzoub J A. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 1988; 85: 5244–5248
  • Petraglia F, Florio P, Simoncini T, Woods R J, Giuntini A, Gremigni R, Serra G B, Genazzani A R, Lowry P J. Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour. Placenta 1997; 18: 115–119
  • Ballard P L, Ballard R A. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995; 173: 254–262
  • Jaffe R B, Mesiano S, Smith R, Coulter C L, Spencer S J, Chakravorty A. The regulation and role of fetal adrenal development in human pregnancy. Endocr Res 1998; 24: 919–926
  • Pepe G J, Albrecht E D. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995; 16: 608–648
  • Gant N F, Hutchinson H T, Siiteri P K, MacDonald P C. Study of the metabolic clearance rate of dehydroisoandrosterone sulfate in pregnancy. Am J Obstet Gynecol 1971; 111: 555–563
  • Pepe G J, Albrecht E D. Regulation of the primate fetal adrenal cortex. Endocr Rev 1990; 11: 148–176
  • Parker L N, Levin E R, Lifrak E T. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985; 60: 947–952
  • Kizildere S, Gluck T, Zietz B, Scholmerich J, Straub R H. During a corticotropin-releasing hormone test in healthy subjects, administration of a beta-adrenergic antagonist induced secretion of cortisol and dehydroepiandrosterone sulfate and inhibited secretion of ACTH. Eur J Endocrinol 2003; 148: 45–53
  • Barrett-Connor E, Khaw K T, Yen S S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986; 315: 1519–1524
  • Moriyama Y, Yasue H, Yoshimura M, Mizuno Y, Nishiyama K, Tsunoda R, Kawano H, Kugiyama K, Ogawa H, Saito Y, Nakao K. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. J Clin Endocrinol Metab 2000; 85: 1834–1840
  • Straub R H, Vogl D, Gross V, Lang B, Scholmerich J, Andus T. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Am J Gastroenterol 1998; 93: 2197–2202
  • Straub R H, Zeuner M, Antoniou E, Scholmerich J, Lang B. Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus. J Rheumatol 1996; 23: 856–861
  • Straub R H, Schuld A, Mullington J, Haack M, Scholmerich J, Pollmacher T. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. J Endocrinol 2002; 175: 467–474

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.